Our CEO was interviewed earlier this week on his recent appointment to the board of the Asian Fund for Cancer Research (AFCR).

"AFCR specifically looks to fund high risk and high impact, similar to Cure Brain Cancer Foundation, they try to focus on supporting researchers and early-stage biotechs. Typically, most people would focus on supporting later stage biotechs.

They also have a USD $600,000 award, the BRACE Award, that supports early-stage biotechs. Similarly, Cure Brain Cancer Foundation has an AUD $2 million brain cancer accelerator that supports Australian and New Zealand biotechs to get up and running." - Lance Kawaguchi, Cure Brain Cancer Foundation CEO.

Watch the full interview: